Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis
Abstract Aim Treatment algorithms define lines of glucose lowering medications (GLM) for the management of type 2 diabetes (T2D), but whether therapeutic trajectories are associated with major adverse cardiovascular events (MACE) is unclear. We explored whether the temporal resolution of GLM usage d...
Main Authors: | Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro, Gian Paolo Fadini |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01600-x |
Similar Items
-
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
by: Enrico Longato, et al.
Published: (2020-06-01) -
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study
by: Enrico Longato, et al.
Published: (2021-11-01) -
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care
by: Mario Luca Morieri, et al.
Published: (2022-12-01) -
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
by: Gian Paolo Fadini, et al.
Published: (2020-04-01) -
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits’ text
by: Alessandro Guazzo, et al.
Published: (2023-11-01)